Edition:
India

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

3.01EUR
17 May 2019
Change (% chg)

€0.05 (+1.52%)
Prev Close
€2.96
Open
€3.00
Day's High
€3.01
Day's Low
€2.98
Volume
12,486
Avg. Vol
42,245
52-wk High
€3.38
52-wk Low
€2.57

Select another date:

Thu, May 2 2019

Photo

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

AstraZeneca ties up with France's Transgene to develop viral immunotherapies

May 2 British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement on Thursday to co-develop five cancer-killing viral immunotherapies.

Select another date: